|
Roldán V, Marín F. Pro: "Antidote for new anticoagulants"--specific target of inhibition requires a specific target for neutralisation. Thromb Haemost. 2012 Oct;108(4):621-2. Epub 2012 Aug 23. Review. PubMed PMID: 22918294.
AÑO: 2012; IF: 6.094
|
|
Roldán V, Marín F. Oral anticoagulation in chronic kidney disease: A huge challenge. Thromb Haemost. 2012 Jul;108(1):3-5. doi: 10.1160/TH12-05-0324. Epub 2012 May 25. PubMed PMID: 22628077.
AÑO: 2012; IF: 6.094
|
|
Roldán V., Marín F., Gallego P., Vicente V., Lip G.Y.H. High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: A reply to a rebuttal. Journal of Thrombosis and Haemostasis. November 2012. 10:2414-2415. 10.1111/j.1538-7836.2012.04918.x
AÑO: 2012; IF: 6.081
|
|
Manzano-Fernández S., Tello-Montoliu A., Marín F. Primary prevention with aspirin in type 2 diabetic patients-searching for the right spot. Circulation Journal. June 2012. 76:1333-1334. 10.1253/circj.CJ-12-0501
AÑO: 2012; IF: 3.578
|
|
Anguita M., Worner F., Domenech P., Marín F., Ortigosa J., Pérez-Villacastín J., Fernández-Ortiz A., Alonso A., Cequier A., Comín J., Heras M., Pan M., Alzueta J., Arenal A., Barón G., Borrás X., Bover R., De La Figuera M., Escobar C., Fiol M., Herreros B., Merino J.L., Mont L., Murga N., Pedrote A., Quesada A., Ripoll T., Rodríguez J., Ruiz M., Ruiz R. New evidence, new controversies: A critical review of the European society of cardiology 2010 clinical practice guidelines on atrial fibrillation. Revista Espanola de Cardiologia. January 2012. 65:7-13. 10.1016/j.recesp.2011.10.003
AÑO: 2012; IF: 3.204
|